1. Home
  2. BBW vs TBPH Comparison

BBW vs TBPH Comparison

Compare BBW & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBW
  • TBPH
  • Stock Information
  • Founded
  • BBW 1997
  • TBPH 2013
  • Country
  • BBW United States
  • TBPH United States
  • Employees
  • BBW N/A
  • TBPH N/A
  • Industry
  • BBW Recreational Games/Products/Toys
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • BBW Consumer Discretionary
  • TBPH Health Care
  • Exchange
  • BBW Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • BBW 786.9M
  • TBPH 699.0M
  • IPO Year
  • BBW 2004
  • TBPH N/A
  • Fundamental
  • Price
  • BBW $49.11
  • TBPH $17.89
  • Analyst Decision
  • BBW Strong Buy
  • TBPH Strong Buy
  • Analyst Count
  • BBW 5
  • TBPH 4
  • Target Price
  • BBW $68.80
  • TBPH $24.25
  • AVG Volume (30 Days)
  • BBW 292.1K
  • TBPH 395.4K
  • Earning Date
  • BBW 12-04-2025
  • TBPH 11-10-2025
  • Dividend Yield
  • BBW 1.78%
  • TBPH N/A
  • EPS Growth
  • BBW 25.62
  • TBPH N/A
  • EPS
  • BBW 4.47
  • TBPH 0.58
  • Revenue
  • BBW $522,518,000.00
  • TBPH $80,327,000.00
  • Revenue This Year
  • BBW $8.36
  • TBPH $79.82
  • Revenue Next Year
  • BBW $3.62
  • TBPH N/A
  • P/E Ratio
  • BBW $11.05
  • TBPH $30.93
  • Revenue Growth
  • BBW 8.10
  • TBPH 27.12
  • 52 Week Low
  • BBW $32.55
  • TBPH $7.90
  • 52 Week High
  • BBW $75.85
  • TBPH $18.96
  • Technical
  • Relative Strength Index (RSI)
  • BBW 32.37
  • TBPH 74.26
  • Support Level
  • BBW $46.02
  • TBPH $14.51
  • Resistance Level
  • BBW $50.38
  • TBPH $18.96
  • Average True Range (ATR)
  • BBW 2.12
  • TBPH 0.77
  • MACD
  • BBW -0.23
  • TBPH 0.38
  • Stochastic Oscillator
  • BBW 26.21
  • TBPH 80.04

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: